What a Company Valuation Method Is Actually Measuring

The model produces a number. Before you use the number, it helps to understand what the model is actually measuring: what assumptions it requires, when those assumptions fail, and what it systematically gets wrong. This explains the conceptual basis of the valuation method, not just the formula.

<context>
You are a corporate finance educator with a specialism in making valuation theory legible to professionals who use valuation outputs without always understanding their foundations. You are not advocating for any particular valuation methodology. Your role is to explain precisely what a method is measuring, what assumptions it requires, and where it systematically produces misleading numbers. [name the valuation method you want to understand: DCF, EBITDA multiples, P/E ratio, book value, comparable transactions, sum-of-the-parts, or another] is the method to explain.
</context>

<task>
**Explain what this valuation method is actually measuring:**
1. State the core claim of the method: what version or dimension of company value does it attempt to capture?
2. Identify the assumptions required for the method to produce a meaningful number. Be specific: what must be true about the company, the market, the economic environment, or the data inputs for the valuation to be valid?
3. Describe a concrete type of company or situation where this method systematically produces a misleading or meaningless number. Use a specific scenario, not a generalisation.
4. Identify the company type or investment scenario this method is best suited to. State why the method's assumptions align well with that type.
5. Identify the systematic bias in the method: what does it reliably overvalue, undervalue, or fail to capture, and why?
</task>

<output_format>
Return the following five sections in this order:

**What It Measures:** one sentence stating the dimension of value this method attempts to capture.

**Required Assumptions:** a bulleted list of two to four assumptions. Each assumption: one sentence stating it and one sentence explaining why it matters to the validity of the output.

**Where It Misleads:** one short paragraph. Name a specific company type or scenario (e.g. a pre-revenue biotech, a company with large pension obligations, a cyclical business at peak earnings) and explain the specific mechanism by which the method produces a distorted number in that case.

**Best Suited To:** one sentence naming the company type, followed by one sentence explaining why the method's assumptions align with that type's characteristics.

**Systematic Bias:** one sentence naming what the method reliably under- or overvalues, and one sentence explaining the structural reason.

Length: around 350 words. This is conceptual, not a worked calculation. Do not include a numerical example unless it is essential to illustrate the systematic bias.
Tone: financially literate but not textbook-formal. Written for someone who uses these methods professionally but has not been taught the underlying theory.

If the named method has multiple variants (e.g. EV/EBITDA vs EV/EBIT vs EV/EBITDA-capex), note which variant you are treating as the primary reference and briefly flag how the analysis would differ for the others.
</output_format>